Dr. Anilkumar Mannava
Dr. Anilkumar Mannava
Consultant Gastroenterologist & Hepatologist
13+ Years of Experience
Dr. Anilkumar Mannava is a leading Consultant Gastroenterologist and Hepatologist in Hyderabad, recognized for his patient-centered approach and clinical expertise in digestive and liver care. With over 13 years of experience, he specializes in diagnosing and treating complex gastrointestinal disorders and liver diseases, including GERD, hepatitis, fatty liver disease, and cirrhosis, with a strong focus on improving his patients’ long-term quality of life.
Beyond clinical practice, Dr. Mannava is an active contributor to gastroenterology research. He has served as principal investigator in multiple gastrointestinal studies and co-led randomized clinical trials evaluating drug therapies for hepatitis, reflecting his commitment to advancing evidence-based liver and digestive disease treatment.
Educational Qualifications
-
DNB (Gastroenterology)
Global Hospital, Lakdikapul, Hyderabad -
MD (General Medicine)
Sri Devaraj Urs Medical College, Kolar, Karnataka -
MBBS
Dr. Pinnamaneni Siddhartha Institute of Medical Sciences & Research Foundation, Vijayawada, Andhra Pradesh (Affiliated to NTR University of Health Sciences)
Dr. Anilkumar Mannava
MD (General Medicine), DNB (Gastroenterology)
Department: GastroenterologyExp: 13 yrsDesignation: Consultant Gastroenterologist and HepatologistLanguages: Telugu, Kannada, English, HindiMed Reg No: 66711Location: Secunderabad
Book an Appointment
Professional Experience
2020 – Present: Consultant Gastroenterologist & Hepatologist
2019: Consultant Gastroenterologist
Global Hospital, Lakdikapul, Hyderabad
2015 – 2016: Senior Resident, General Medicine
KMC, Mangalore
2014 – 2015: Senior Resident, General Medicine
KMC, Manipal
2011 – 2014: Junior Resident, General Medicine
Sri Devaraj Urs Medical College, Kolar
Core Services
Therapeutic Endoscopy & Colonoscopy
Therapeutic ERCP
Spyglass Cholangioscopy
Interventional Biliary & Pancreatico EUS
Peroral Endoscopic Myotomy (POEM)
Third Space Endoscopy
Endoscopic Mucosal Resection (EMR)
Endoscopic Mucosal Dissection (ESD)
Areas of Special Interest & Expertise
Advanced Therapeutic Endoscopy
ERCP & EUS
Third Space Endoscopy Techniques
Endoscopic Bariatric Procedures
Clinical Research in Gastroenterology & Hepatology
Research & Publications
-
Prevalence of Functional Dyspepsia in a Rural Medical College Hospital – Published in Journal of Evolution of Medical and Dental Sciences, 2014
-
Jaundice Evaluation in Medical Wards – Published in Journal of Biological and Scientific Opinion, 2014
-
Acute Methemoglobinemia Due to Nitrobenzene Poisoning: Case Series – Published in International Journal of Medical Research & Health Sciences, 2014
-
A Rare Case of Snake Bite with Severe Isolated Hematotoxicity – Published in Journal of Clinical and Biomedical Sciences, 2011
-
Prevalence of Functional Dyspepsia – Presented at KAPICON 2012, Hassan
-
ICU Admission Characteristics and Outcomes in Elderly Patients – Presented at KAPICON 2013, Mangalore
-
Correlation of Insulin Resistance and Dyslipidemia in NAFLD – Presented at KRSSDI 2014, Belgaum
-
SNPs in PNPLA3, APOC3 and TM6SF2 Genes in NAFLD – Presented at APDW 2019, Kolkata
-
Sudden Sensorineural Hearing Loss in Type 1 Diabetes with DKA – Presented at KAPICON 2012, Hassan
-
Jaundice Evaluation in Medical Wards – Presented at APICON 2013, Coimbatore
-
Management of a Patient Waitlisted for Liver Transplant – Published in ISGCON Yearbook, 2017
-
Beta Blockers in Cirrhosis of Liver – Published in Gastroenterology Update, ISG, 2018
-
Acute Liver Failure – Published in Clinical Gastroenterology, 4th Ed., Paras Medical Publisher, 2020
-
Renal Dysfunction in Chronic Liver Disease – Published in Clinical Gastroenterology, 4th Ed., Paras Medical Publisher, 2020
-
Phase IV Study: Sofosbuvir/Daclatasvir in Genotype 3 HCV – Protocol ID: MYL-MHD-4001
-
Phase 3 Study: Selonsertib in Compensated Cirrhosis (NASH) – Protocol ID: GS-US-384-1944
-
Phase 3 Study: Selonsertib in NASH with Bridging Fibrosis – Protocol ID: GS-US-384-1943
-
Phase IV Study: MyHep LVIR™ & MyDekla™ in HCV Genotype 1 & 3 – Protocol ID: MYL-SLD-4001
-
Phase IV Study: MyHep All™ in Chronic HCV – Protocol ID: MYL-MYV-4001
-
Phase 3 Study: Tenofovir Alafenamide vs TDF in Chronic Hepatitis B – Protocol ID: GS-US-320-0110
-
Post-Marketing Study: Sofosbuvir-Based Regimens in HCV – Protocol ID: GS-US-334-1775
-
Phase 3 Study: Sofosbuvir/Velpatasvir in Chronic HCV – Protocol ID: GS-US-342-1521